Back to Agenda
S06 : "Let's Dialogue about the Future of Treatment Development for Rare Cancers -Steps Toward Unmet Needs-"
Session Chair(s)
Kenichi Nakamura, MD, PhD, MBA
Chief, Department of International Clinical Development, National Cancer Center Hospital, Japan
S06 : "Let's Dialogue about the Future of Treatment Development for Rare Cancers -Steps Toward Unmet Needs-"
Speaker(s)
A Platform Study for Rare Cancers: MASTER KEY Japan and Asia
Hitomi Okuma, MD, PhD
Head, International Research and Development Section, National Cancer Center Hospital, Japan
Consideration of Unmet Needs from the Cancer Patient's Perspective
Sumito Nishidate
Vice Chairman, Rare Cancers Japan, Japan
Pharmaceutical Company Perspective on Current and Future Clinical Development in Rare Cancers
Yuichi Hirata
Head of Oncology Pipeline Group, TA-Oncology, Nippon Boehringer Ingelheim Co., Ltd., Japan
Takuji Ueno
Assistant Director, Cancer and Disease Control Division, Ministry of Health, Labour and Welfar (MHLW), Japan
Have an account?